Top 10 Organoid Companies
The past year marked a proverbial inflection point for organoid models designed to uncover biological insights previously unattainable through traditional cell culture experiments or animal models.
The FDA in October approved the first-ever investigational new...
AGBT 2026 Recap: NGS Big Bets and Spatial’s Rising Momentum
For most people, February in Florida means school breaks, water parks, and trips to Disney. But for the genomics community, that combination means the season of big announcements as the Advances in Genome Biology...
New drying technique stabilizes vital vaccines at room temperature
A significant challenge in global healthcare and biotechnology is the "cold chain"-the network of refrigerated storage and transport required to keep protein-based drugs, vaccines, and diagnostic tests from degrading. This reliance on constant low...
US scientists sequence 1,000 genomes from measles, a disease long eliminated with vaccines
This week, the Centers for Diseases Control and Prevention posted online its first large tranche of advanced genetic data from measles viruses spreading last year. Scientists with knowledge of the operation expect the agency...
Cancer Vaccine Design Gets Personal
The landscape of cancer immunotherapies is evolving rapidly. Although peptides or mRNA vaccines encapsulated in lipid nanoparticles are the most popular platform for personalized cancer vaccines (PVCs), drugmakers are exploring other technologies in the...
“Smart” system distinguishes and neutralizes cancer cells with unprecedented precision
A team from UNIGE has designed a molecular system that distinguishes and neutralizes cancer cells with unprecedented precision, paving the way for autonomous, self-regulating drugs. How can cancer cells be targeted without damaging healthy...
Expanding the Toolbox for Mammalian Genome Engineering
Sponsored content brought to you by
Across biomanufacturing, disease modeling, synthetic biology, and cell therapy development, researchers increasingly need to insert large DNA constructs into mammalian genomes. Yet despite significant advances in genome editing technologies...
Broken String Biosciences rebrands to reflect strategic evolution as demand grows for unbiased genome-wide...
Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today introduced new branding and comprehensive website as part of its strategic repositioning. At a...
Collaboration advances EMA601 as potential first-in-class stroke therapy
Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license agreement for the preclinical development program of the GPVI‑blocking antibody EMA601. University Hospital Würzburg has supported the development...
Common Ancestry Limits Protein Sequence Exploration, Computational Study Shows
For all the excitement surrounding AlphaFold and the surge of AI‑driven protein design tools, one fact often goes unexamined: nearly every model is trained on databases of known proteins. These databases feel vast, but...
